Quanterix Corporation (QTRX)Healthcare | Medical Devices | Billerica, United States | NasdaqGM
3.36 USD
+0.06
(1.788%)
⇧
(April 21, 2026, 10:33 a.m.
EDT)
Short-term: ★☆☆☆☆ | Long-term: ★★★☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 19, 2026, 12:02 a.m. EDT
Quanterix (QTRX) is a fundamental value trap in a short-term downtrend, trading at a 0.33x discount to its books but reflecting terrible equity creation and negative analyst revisions. The recent news cycle of executives exercising shares and trimming holdings, combined with the stock trading significantly below its 50-day moving average, creates a high-risk environment for momentum traders. The prediction model suggests a -1% downside over the next month, confirming the bearish technicals. While the medical device technology is promising, the balance sheet erosion (negative free cash flow and operating margins) and lack of a current dividend make this a speculative hold-at-least, not a buy-and-hold play. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.318095 |
| AutoARIMA | 0.321872 |
| AutoETS | 0.321876 |
| AutoTheta | 0.404041 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 37.92 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.094 |
| Excess Kurtosis | -1.52 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 12.592 |
| Revenue per Share | 3.258 |
| Market Cap | 157,671,376 |
| Forward P/E | -1.76 |
| Beta | 1.32 |
| Profit Margins | -77.14% |
| Website | https://www.quanterix.com |
As of April 19, 2026, 12:02 a.m. EDT: Options flow reveals a mixed but predominantly bearish-to-neutral sentiment. Speculators are positioning with high implied volatility for downside protection in the near term (April 17 ATM put IV 5.19 vs call IV 4.69). The 5-month expiry shows significant Out-of-the-Money (OTM) call Open Interest (OI) anchored at 7.5 strikes, suggesting a speculative target that is unlikely to be met soon. However, the immediate near-term flow is dominated by ATM positioning at 2.5 and 5.0 strikes, indicating a lack of strong directional conviction. No significant 'unusual flow' or heavy directional gamma accumulation is observed compared to the volatility crush in longer-dated legs.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.3604651 |
| Address1 | Building 1 |
| Address2 | 900 Middlesex Turnpike |
| All Time High | 92.57 |
| All Time Low | 3.23 |
| Ask | 4.19 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Analyst Rating | 3.0 - Hold |
| Average Daily Volume10 Day | 969,170 |
| Average Daily Volume3 Month | 774,973 |
| Average Volume | 774,973 |
| Average Volume10Days | 969,170 |
| Beta | 1.316 |
| Bid | 2.44 |
| Bid Size | 1 |
| Board Risk | 4 |
| Book Value | 6.327 |
| City | Billerica |
| Compensation As Of Epoch Date | 1,735,603,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.359 |
| Current Ratio | 2.839 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 3.405 |
| Day Low | 3.2613 |
| Debt To Equity | 12.592 |
| Display Name | Quanterix |
| Earnings Call Timestamp End | 1,772,487,000 |
| Earnings Call Timestamp Start | 1,772,487,000 |
| Earnings Timestamp | 1,772,485,200 |
| Earnings Timestamp End | 1,778,184,000 |
| Earnings Timestamp Start | 1,778,184,000 |
| Ebitda | -71,927,000 |
| Ebitda Margins | -0.51784 |
| Enterprise To Ebitda | -1.028 |
| Enterprise To Revenue | 0.532 |
| Enterprise Value | 73,908,920 |
| Eps Current Year | -2.08 |
| Eps Forward | -1.91 |
| Eps Trailing Twelve Months | -2.51 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 4.7434 |
| Fifty Day Average Change | -1.3844001 |
| Fifty Day Average Change Percent | -0.2918582 |
| Fifty Two Week Change Percent | -36.046513 |
| Fifty Two Week High | 8.77 |
| Fifty Two Week High Change | -5.4110003 |
| Fifty Two Week High Change Percent | -0.61698973 |
| Fifty Two Week Low | 3.23 |
| Fifty Two Week Low Change | 0.12899995 |
| Fifty Two Week Low Change Percent | 0.039938066 |
| Fifty Two Week Range | 3.23 - 8.77 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,512,657,000,000 |
| Float Shares | 36,817,839 |
| Forward Eps | -1.91 |
| Forward P E | -1.7586387 |
| Free Cashflow | -7,033,875 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 450 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.46768 |
| Gross Profits | 64,959,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.06235 |
| Held Percent Institutions | 0.83827 |
| Implied Shares Outstanding | 46,939,975 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Quanterix Corporation, a life sciences company in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, the company offers contract research and clinical laboratory testing services, including research and clinical trial testing, and lucent diagnostic services. The company primarily operates in the areas of neurology, oncology and immunology, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and sales force and distributors. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts. |
| Long Name | Quanterix Corporation |
| Market | us_market |
| Market Cap | 157,671,376 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_47689694 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -107,150,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 154,901,917 |
| Number Of Analyst Opinions | 3 |
| Open | 3.3 |
| Operating Cashflow | -77,236,000 |
| Operating Margins | -0.48194999 |
| Overall Risk | 6 |
| Payout Ratio | 0.0 |
| Phone | 617 301 9400 |
| Previous Close | 3.3 |
| Price Eps Current Year | -1.6149039 |
| Price Hint | 4 |
| Price To Book | 0.5308993 |
| Price To Sales Trailing12 Months | 1.1351677 |
| Profit Margins | -0.77142996 |
| Quick Ratio | 1.982 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | hold |
| Recommendation Mean | 3.0 |
| Region | US |
| Regular Market Change | 0.059000015 |
| Regular Market Change Percent | 1.7878792 |
| Regular Market Day High | 3.405 |
| Regular Market Day Low | 3.2613 |
| Regular Market Day Range | 3.2613 - 3.405 |
| Regular Market Open | 3.3 |
| Regular Market Previous Close | 3.3 |
| Regular Market Price | 3.359 |
| Regular Market Time | 1,776,782,024 |
| Regular Market Volume | 69,862 |
| Return On Assets | -0.13112001 |
| Return On Equity | -0.34245998 |
| Revenue Growth | 0.247 |
| Revenue Per Share | 3.258 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 46,939,975 |
| Shares Percent Shares Out | 0.0919 |
| Shares Short | 4,315,137 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 4,117,679 |
| Short Name | Quanterix Corporation |
| Short Percent Of Float | 0.097399995 |
| Short Ratio | 5.29 |
| Source Interval | 15 |
| State | MA |
| Symbol | QTRX |
| Target High Price | 8.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.66667 |
| Target Median Price | 7.0 |
| Total Cash | 118,232,000 |
| Total Cash Per Share | 2.519 |
| Total Debt | 37,239,000 |
| Total Revenue | 138,896,992 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.51 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 5.6276 |
| Two Hundred Day Average Change | -2.2686002 |
| Two Hundred Day Average Change Percent | -0.40312037 |
| Type Disp | Equity |
| Volume | 69,862 |
| Website | https://www.quanterix.com |
| Zip | 1,821 |